Biodesign is an innovation program for medical device development, on the basis of the design thinking that was launched at Stanford University in 2001. The program is characterized by its unique approach, which starts from unmet clinical needs in healthcare settings and incorporates a commercialization perspective from the early stages of development. Beyond providing solutions for medical device development, Biodesign also cultivates the ability to identify valuable insights for new product creation and to evaluate opportunities from a venture capital (VC) perspective.​

　Hiroshima University will launch the Hiroshima Biodesign Fellowship Program to deliver this educational framework. We warmly invite motivated participants to join the program.​

・Interested in innovation in medical & healthcare devices​
・Working people (company employees, medical doctors, healthcare professionals, researchers, entrepreneurs, etc.)​
・Graduate students in medical or engineering​
・Potential leadership, creativity, and teamwork skills to become leaders in medical & healthcare device innovation​
・Diverse backgrounds.

・Capacity: 4-5 participants
・Fee: Please contact us
・Duration: July - December 2026 (Tentative)​
（ The tentative weekly schedule is Tuesday and ​Wednesday evenings. The expected weekly time ​　commitment is 15 hours or more in total. ）
・Location: Hiroshima University, Kasumi Campus
       (1-2-3 Kasumi, Minami-ku, Hiroshima)
・Information: A certificate will be issued upon program completion
・Application Deadline: By April 30th, 2026
・How to Apply: Please contact us

 Hiroshima University, Biodesign Division, Department of Industry-Academia Collaboration, Open Innovation Headquarters, Office for Academic and Social Cooperation​
Tel: 082-257-1992 Mail: biodesign@office.hiroshima-u.ac.jp​